Cipher Pharmaceuticals

(TSX) CPH

Current Price$18.36

Market Cap$467.95M

Since IPO (2004)+400%

5 Year+1,292%

1 Year+49%

1 Month+7%

Cipher Pharmaceuticals Financials at a Glance

Market Cap

$467.95M

Revenue (TTM)

$50.64M

Net Income (TTM)

$27.53M

EPS (TTM)

$1.46

P/E Ratio

12.38

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$18.36

Volume

4,960

Open

$18.49

Price

$18.36

Volume

4,960

Open

$18.49

Previous Close

$18.51

Daily Range

$18.29 - $18.56

52-Week Range

$11.87 - $19.63

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$18.36

Volume

4,960

Open

$18.49

Previous Close

$18.51

Daily Range

$18.29 - $18.56

52-Week Range

$11.87 - $19.63

CPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cipher Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Craig Mull

Website

www.cipherpharma.com

Headquarters

Mississauga, ON L6H 0M2, CA

CPH Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

33%

Net Income Margin

54%

Return on Equity

24%

Return on Capital

13%

Return on Assets

18%

Earnings Yield

8.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$467.95M

Shares Outstanding

25.28M

Volume

4.96K

Avg. Volume

31.00K

Financials (TTM)

Gross Profit

$33.77M

Operating Income

$16.80M

EBITDA

$16.80M

Operating Cash Flow

$30.25M

Capital Expenditure

$28.49K

Free Cash Flow

$30.22M

Cash & ST Invst.

$7.48M

Total Debt

$5.49M

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$12.41M

+4.9%

Gross Profit

$8.23M

+23.0%

Gross Margin

66.36%

N/A

Market Cap

$467.95M

N/A

Market Cap/Employee

$93.59M

N/A

Employees

N/A

Net Income

$13.52M

+304.2%

EBITDA

$4.27M

+131.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.98M

+108.7%

Accounts Receivable

$11.19M

-19.3%

Inventory

$8.18M

+41.1%

Long Term Debt

$5.21M

-87.1%

Short Term Debt

$288.47K

+1.9%

Return on Assets

17.63%

N/A

Return on Invested Capital

12.73%

N/A

Free Cash Flow

$8.84M

-0.4%

Operating Cash Flow

$8.87M

-0.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NGEN.VNervGen Pharma Corp.

NGEN.VNervGen Pharma Corp.$5.15+3.00%

EDT.TOSpectral Medical Inc.

EDT.TOSpectral Medical Inc.$1.39+0.72%

TSND.TOTerrAscend Corp.

TSND.TOTerrAscend Corp.$1.01-5.61%

HITI.VHigh Tide Inc.

HITI.VHigh Tide Inc.$3.44-0.86%

WEED.TOCanopy Growth Corporation

WEED.TOCanopy Growth Corporation$1.59-3.05%

FRX.TOFennec Pharmaceuticals Inc.

FRX.TOFennec Pharmaceuticals Inc.$9.60+2.13%

ACB.TOAurora Cannabis Inc.

ACB.TOAurora Cannabis Inc.$4.67-2.51%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$10.98+0.03%

POETPoet Technologies

POETPoet Technologies$7.63-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.10+0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.11-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.13-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$54.58+0.04%

BBBYBeyond, Inc.

BBBYBeyond, Inc.$5.12-0.04%

Questions About CPH

What is the current price of Cipher Pharmaceuticals?

Cipher Pharmaceuticals is trading at CA$18.36 per share.

What is the 52-week range for Cipher Pharmaceuticals?

Over the past 52 weeks, Cipher Pharmaceuticals has traded between CA$11.87 and CA$19.63.

How much debt does Cipher Pharmaceuticals have?

As of the most recent reporting period, Cipher Pharmaceuticals reported total debt of $7.55M.

How much cash does Cipher Pharmaceuticals have on hand?

Cipher Pharmaceuticals reported $10.27M in cash and cash equivalents in its most recent financial results.

What is Cipher Pharmaceuticals’s dividend yield?

Cipher Pharmaceuticals does not currently have a dividend yield.

Cipher Pharmaceuticals

Cipher Pharmaceuticals Financials at a Glance

CPH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cipher Pharmaceuticals

CPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPH

What is the current price of Cipher Pharmaceuticals?

What is the 52-week range for Cipher Pharmaceuticals?

How much debt does Cipher Pharmaceuticals have?

How much cash does Cipher Pharmaceuticals have on hand?

What is Cipher Pharmaceuticals’s dividend yield?

Premium Investing Services